Growth Metrics

Nexalin Technology (NXL) Equity Ratio (2021 - 2025)

Nexalin Technology has reported Equity Ratio over the past 5 years, most recently at 0.81 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.81 for Q4 2025, down 7.12% from a year ago — trailing twelve months through Dec 2025 was 0.81 (down 7.12% YoY), and the annual figure for FY2025 was 0.81, down 7.12%.
  • Equity Ratio for Q4 2025 was 0.81 at Nexalin Technology, down from 0.93 in the prior quarter.
  • Over the last five years, Equity Ratio for NXL hit a ceiling of 0.94 in Q3 2024 and a floor of 2.23 in Q4 2021.
  • Median Equity Ratio over the past 5 years was 0.81 (2025), compared with a mean of 0.63.
  • Biggest five-year swings in Equity Ratio: skyrocketed 133.03% in 2022 and later decreased 7.12% in 2025.
  • Nexalin Technology's Equity Ratio stood at 2.23 in 2021, then skyrocketed by 133.03% to 0.74 in 2022, then grew by 19.77% to 0.88 in 2023, then dropped by 1.4% to 0.87 in 2024, then fell by 7.12% to 0.81 in 2025.
  • The last three reported values for Equity Ratio were 0.81 (Q4 2025), 0.93 (Q3 2025), and 0.91 (Q2 2025) per Business Quant data.